Allianz's Record Half-Year Meets a Market That Won't Fully Buy the Story
Published on 09/10/2026 at 12:40 | Editorial boerse-global.de
Allianz SE delivered its strongest first half on record, yet the equity is having trouble converting that performance into fresh momentum. Operating profit for the period reached EUR 9.4 billion, an 8.6 percent advance on the prior-year figure, and chief executive Oliver Bäte used the occasion to reaffirm the group's full-year target of EUR 17.4 billion — bracketed by a tolerance band of plus or minus EUR 1 billion.
The capital position underpinning that guidance looks sturdy. Allianz's Solvency II ratio climbed to 225 percent at the half-year mark, up from 218 percent at the close of fiscal 2025. That buffer matters at a moment when the insurer is weighing several strategic moves at once, among them a potential takeover of UK roadside assistance provider AA and a possible deal for Danish investment manager Capital Four, which would deepen the group's private markets footprint. The Pimco stake increase completed more than a month ago already signaled management's appetite for deployment.
Buyback Keeps Grinding
Capital discipline is visible on a second front as well. Of the EUR 2.5 billion earmarked for the current repurchase program, EUR 1.4 billion had been used by the end of the first half of 2026. The steady bid for its own stock has provided a technical floor for the shares, even through the softer patches of recent weeks.
The scale of that program is easier to grasp in share terms. Between August 24 and 28 alone, Allianz picked up another 57,715 of its own shares, bringing the total bought back since the program began on March 13 to 5,448,823. Each retirement of stock mechanically lifts earnings per share, which is precisely the kind of arithmetic support that keeps a richly valued name from drifting too far.
A Leadership Reshuffle for 2027
Behind the numbers, the supervisory board is reshaping the executive floor. Handelsblatt reported in late July that Günther Thallinger will leave the management board at the end of the year, trimming the body from nine members to eight. Tomas Kunzmann, currently head of Allianz Partners, will step up at the turn of 2027 and take charge of the Asia-Pacific region including India.
Should investors sell immediately? Or is it worth buying Allianz?
The reshuffle lands while the group is simultaneously evaluating its options — the AA question, the Capital Four talks, and the integration of its expanded Pimco holding all competing for management attention.
Where the Shares Stand
On the screen, the picture is one of consolidation rather than distress. The stock trades at EUR 439.40, roughly one percent above the previous close of EUR 435.20. That leaves it just 3.3 percent below its 52-week high of EUR 454.50, set in early September, and up 12 percent since the start of the year.
The pullback from that peak amounts to 4.2 percent, with 4.0 percent of the decline coming in the last seven trading sessions alone. Momentum readings reflect the pause: an RSI of 42.9 points to neutral-to-cooled sentiment — neither oversold nor attracting aggressive buying. Wednesday's session alone saw a 1.8 percent drop.
Longer-term trend markers, though, remain constructive. The shares sit 11 percent above their 200-day moving average of EUR 391.77 and almost exactly on the 50-day line of EUR 433.96. Over twelve months the gain reaches 24 percent, against 11 percent year-to-date. Annualized volatility is running at a moderate 13 percent.
The Analyst Gap
The tension in the story is the distance between the market price and at least one prominent sell-side view. Barclays raised its target on September 4 — but only from EUR 350 to EUR 353, while keeping an "Underweight" rating. That target sits far below the current EUR 435.20 level, implying the broker sees the valuation as stretched rather than the operating performance as underappreciated.
Bulls counter that the buyback's persistent demand and the intact medium-term uptrend argue for stabilization. Should the AA acquisition — a reported GBP 5 billion transaction that Allianz has not confirmed — firm up, it could be read as a push into a higher-margin service business with its own earnings potential. Skeptics see it differently: an unconfirmed deal of that size carries integration risk and would tie up capital that might otherwise fund distributions or further repurchases.
What happens next hinges on two things. First, whether Allianz provides clarity on the AA situation. Second, whether the buyback — whose next weekly update is due — retains its supporting effect. A slip below the 50-day average near EUR 434, compounded by further analyst caution echoing Barclays, would give the correction room to run. Hold above the 200-day line at EUR 391.77 with repurchases continuing, and the base case is a stabilization around present levels.
Investors get their next hard data point on November 12, when Allianz publishes its third-quarter statement. Until then, the AA talks are likely to dominate attention — and the stock remains a tug-of-war between genuine fundamental strength and the valuation reservations of its critics.
Ad
Allianz Stock: New Analysis - 10 September
Fresh Allianz information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
